AMARANTUS BIOSCI INC (OTC: AMBS) slipped 6.64% to $0.134. The stock opened at $0.13. The Company announced that Dr. John W. Commissiong, CSO will present results of its MANF Parkinson's disease neurorestoration animal studies at the OneMedForum SF 2013 conference on January 8, 2013. The organization is a development stage biotechnology company, focuses on the discovery and development of therapeutic proteins and biologics for the treatment of Parkinson disease, traumatic brain injury and other human diseases in the United States.
Will AMBS Move Higher After Today’s Sudden Selling Activities? Don’t Miss The Free Trend Analysis here http://beststocksdaily.com/p2/index.php?company=AMBS
USA Graphite Inc (OTC: USGT) surged up 3.14% to $0.949 on a traded volume of 616k shares. The Company informed its shareholders of its activities in selecting the location of a high-quality Canadian project for a potential acquisition. The Company has identified the West Coast of Canada as the ideal location to acquire a project that would significantly increase the Company's operations. Eagle Graphite, which is a privately held Canadian corporation, is located on the West Coast of Canada and is one of only two natural flake graphite mines operating in North America.
Carbonite Inc (NASDAQ: CARB) increased 0.21% to $9.65. The Company appointed Anthony Folger as the Chief Financial Officer and Treasurer. Folger, who joins the Company effective, will be responsible for financial strategy and operations.
Southridge Enterprises Inc (PINKSHEETS: SRGE) is currently trading at $0.0057. So far this year, the stock is up over 1533%. The 52-week range for the stock is $0.0 and $0.02. Southridge Minerals focuses on the acquisition, exploration, and development of gold and silver mines in Mexico.
Peregrine Pharmaceuticals (NASDAQ: PPHM) soared 6.59% to $2.60 on a traded volume of 11.57 million shares. The Company said flaws in a study of its experimental lung cancer drug bavituximab didn’t extend to the highest treatment dose. An internal review found that discrepancies in a mid-stage study were limited to the placebo and low-dose treatments.
Beststocksdaily’s team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdaily’s instant stock news on Major Gainers, Hot Stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Beststocksdaily.com.
The assembled information disseminated by beststocksdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. beststocksdaily.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
1419 Westwood Blvd Los Angeles, CA